Literature DB >> 17406200

Hypertensive retinopathy associated with use of the ephedra-free weight-loss herbal supplement Hydroxycut.

Scott L Willis1, Fouad J Moawad, Joshua D Hartzell, Melissa Iglesias, William L Jackson.   

Abstract

The use of performance-enhancing and weight-loss supplements is prevalent in the United States, and over the past decade, there has been growing concern with regard to the safety and efficacy of these products. It is well documented that ephedra-based products are associated with adverse reactions, including serious cardiovascular and neurologic injuries. With new restrictions placed on such products, companies are now marketing caffeine-based ephedra-free herbal supplements. Less is known about the potential side effects of these products. We present the case of a 42-year-old, previously healthy man who developed malignant hypertension and hypertensive retinopathy while taking Hydroxycut, a caffeine-based ephedra-free supplement. To our knowledge, this is the first documented case of hypertensive retinopathy associated with the use of Hydroxycut. Given the lack of investigative studies in regard to their safety and efficacy, judicious care should be taken with the use of all herbal supplements, including those designated as ephedra-free.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406200      PMCID: PMC1781262     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  11 in total

1.  The relative safety of ephedra compared with other herbal products.

Authors:  Stephen Bent; Thomas N Tiedt; Michelle C Odden; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2003-03-18       Impact factor: 25.391

Review 2.  Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously.

Authors:  Jack E James
Journal:  Psychosom Med       Date:  2004 Jan-Feb       Impact factor: 4.312

Review 3.  Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.

Authors:  Shannon Corey Miller
Journal:  Mil Med       Date:  2004-02       Impact factor: 1.437

Review 4.  Hypertensive retinopathy.

Authors:  Tien Y Wong; Paul Mitchell
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

5.  Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut.

Authors:  Tyler Stevens; Asif Qadri; Nizar N Zein
Journal:  Ann Intern Med       Date:  2005-03-15       Impact factor: 25.391

6.  Recent trends in use of herbal and other natural products.

Authors:  Judith P Kelly; David W Kaufman; Katherine Kelley; Lynn Rosenberg; Theresa E Anderson; Allen A Mitchell
Journal:  Arch Intern Med       Date:  2005-02-14

7.  Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.

Authors:  Nicole C Bouchard; Mary Ann Howland; Howard A Greller; Robert S Hoffman; Lewis S Nelson
Journal:  Mayo Clin Proc       Date:  2005-04       Impact factor: 7.616

Review 8.  Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system.

Authors:  P M Dodson; G Y Lip; S M Eames; J M Gibson; D G Beevers
Journal:  J Hum Hypertens       Date:  1996-02       Impact factor: 3.012

9.  Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose.

Authors:  Fouad J Moawad; Joshua D Hartzell; Timothy J Biega; Christopher J Lettieri
Journal:  South Med J       Date:  2006-05       Impact factor: 0.954

10.  Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine.

Authors:  Javed M Nasir; Steven J Durning; Michael Ferguson; Helen S Barold; Mark C Haigney
Journal:  Mayo Clin Proc       Date:  2004-08       Impact factor: 7.616

View more
  3 in total

1.  What's new about inflammatory bowel diseases in Ischemic colitis induced by the newly reformulated multicomponent weight-loss supplement Hydroxycut(®).

Authors:  Muhammed Sherid; Salih Samo; Samian Sulaiman; Joseph H Gaziano
Journal:  World J Gastrointest Endosc       Date:  2013-04-16

2.  Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report.

Authors:  Gregory L Cvetanovich; Pankajavalli Ramakrishnan; Joshua P Klein; Vikram R Rao; Allan H Ropper
Journal:  J Med Case Rep       Date:  2011-11-10

Review 3.  A Review of the Ephedra genus: Distribution, Ecology, Ethnobotany, Phytochemistry and Pharmacological Properties.

Authors:  Daphne E González-Juárez; Abraham Escobedo-Moratilla; Joel Flores; Sergio Hidalgo-Figueroa; Natalia Martínez-Tagüeña; Jesús Morales-Jiménez; Alethia Muñiz-Ramírez; Guillermo Pastor-Palacios; Sandra Pérez-Miranda; Alfredo Ramírez-Hernández; Joyce Trujillo; Elihú Bautista
Journal:  Molecules       Date:  2020-07-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.